Marriott International's (NASDAQ: MAR) share price took off in November following positive news on the coronavirus vaccine front. The good news continued: State and federal government agencies, along with pharmaceutical companies, have begun distributing approved vaccines, while provider networks are administering the shots.
However, while everyone hopes for a return to normalcy, is investor optimism in Marriott warranted right now?
Marriott maintains 30 hotel brands, including those at the select level (e.g., Courtyard, Residence Inn, and Fairfield); premium (e.g., Marriott, Sheraton, and Westin); and luxury (e.g., JW Marriott, Ritz-Carlton, and W Hotels).
Source Fool.com